The HCPLive acute pain medicine page is a comprehensive resource for clinical news and insights on pain treatment. This page consists of interviews, articles, podcasts, and videos on the research, treatment, and development of therapies for acute pain, injuries, and more.
January 30th 2024
VX-548 demonstrated a more rapid onset to meaningful pain relief post-surgery compared with placebo.
Urine Drug Testing: Why Do It?
December 8th 2014Many clinicians and academicians believe that stipulation for random urine drug testing should be a part of any opioid agreement, with UDT serving the dual purposes of ensuring compliance with prescribed opioids as well as monitoring use of illicit drugs and non-prescribed medications.
Acetaminophen in Treatment of Lower Back Pain
September 3rd 2014Many guidelines recommend the use of acetaminophen (called paracetamol in Europe) and/or NSAIDs for the treatment of acute low back pain. The reason for this is acetaminophen and NSAIDs are relatively safe and effective with regard to managing musculoskeletal pain. This study determined the efficacy of acetaminophen alone vs. placebo for acute low back pain.
Opioid Risk Mitigation- Part 1
September 2nd 2014While opioids represent an important tool in treating pain, it would be foolish to not acknowledge that opioids and opioid prescribing are fraught with potential hazards. However, through the development of a strong risk mitigation platform, primary care physicians can minimize the risks to their patients, as well as to their own practices.
The Value of Imaging Studies for Acute, Nonspecific Low Back Pain
When a patient arrives at a hospital or other urgent care center, there are seemingly endless tests that can be undertaken to appropriately diagnose the patient. A recent study reviewed the necessity of some tests, particularly in regard to acute, nonspecific lower back pain.
FDA Approves Zorvolex for the Treatment of Osteoarthritis Pain
August 25th 2014Clinicians who treat patients suffering with osteoarthritis pain have a new low-dose nonsteroidal anti-inflammatory drug (NSAID) option at their disposal. Zorvolex (diclofenac) was developed to meet prevailing FDA recommendations regarding NSAID dosing and treatment duration.